ABC aired a special from Oprah Winfrey last night about how new GLP-1 drugs are helping patients and changing the perception of obesity as a disease rather than a failure of willpower, giving even more exposure to Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. Read the full article here.
The wearable combines AI and neurotechnology to modulate the nervous system to help alleviate functional limitations caused by tremors. The company's AI continuously adjusts stimulation parameters to provide therapy that calms tremors and helps restore motor control.
Read more here.
A technology-driven overhaul of the NHS could add £40bn a year to the UK economy and increase healthy life expectancy for millions, a new report suggests.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us